NTRK fusions are recently discovered biomarkers that play an important role in the response to TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events and, in the future, may change the way we approach cancer.
Accurate and comprehensive detection of NTRK fusions is difficult because NTRK genes include:
Amongst the variable performance of NTRK fusion assays, NTRK detection from RNA using hybrid-capture next-generation sequencing provides comprehensive and accurate fusion detection, agnostic of the fusion partner.
View the webinar to learn more.